Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Bonelli, RM; Mahnert, FA; Niederwieser, G.
Olanzapine for Huntington's disease: an open label study.
CLIN NEUROPHARMACOL. 2002; 25(5): 263-265. Doi: 10.1097%2F00002826-200209000-00007
Web of Science PubMed FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Bonelli Raphael
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
The aim of this prospective open label study was to assess the efficacy of olanzapine for motor symptoms in Huntington's disease (HD). Olanzapine was administrated to nine patients with genetically confirmed HD in increasing doses until satisfactory clinical effect or the appearance of side effects. The patients were evaluated at baseline and after 14 days of treatment using the motor scale of the Unified HD Rating Scale (UHDRS). The patients improved significantly in most subscores of the UHDRS, including fine motor tasks, although some patients needed a rather high dose (30 mg per day). No adverse effects were reported by the patents spontaneously or were observed directly by the investigator. High-dose olanzapine seems to be useful in choreatic HD patients. A double blind, placebo-controlled trial appears warranted to definitively establish the symptomatic value of olanzapine in HD.
Find related publications in this database (using NLM MeSH Indexing)
Adult -
Antipsychotic Agents - therapeutic use
Benzodiazepines - therapeutic use
Dose-Response Relationship, Drug - therapeutic use
Double-Blind Method - therapeutic use
Female - therapeutic use
Humans - therapeutic use
Huntington Disease - drug therapy
Male - drug therapy
Middle Aged - drug therapy
Pirenzepine - analogs and derivatives
Prospective Studies - analogs and derivatives
Psychiatric Status Rating Scales - statistics and numerical data
Severity of Illness Index - statistics and numerical data
Time Factors - statistics and numerical data
Treatment Outcome - statistics and numerical data

Find related publications in this database (Keywords)
Huntington's disease
olanzapine
chorea
neuroleptics
© Med Uni Graz Impressum